Allergen immunotherapy: progress and future outlook.

Area of Science:

• Immunology
• Allergology
• Pharmacology

Background:

• Allergy is a global health issue caused by hypersensitivity to environmental compounds like pollen and food.
• Symptoms range from mild to life-threatening, with most patients self-treating symptomatically.
• Allergen immunotherapy (AIT) is the only causative treatment but has limitations.

Purpose of the Study:

• To review current allergy management strategies.
• To highlight advancements in biologics and biomarkers.
• To discuss emerging research trends in allergen immunotherapy (AIT).

Main Methods:

• Review of state-of-the-art allergy management.
• Emphasis on current research in AIT.
• Discussion of novel therapeutic approaches.

Main Results:

• Conventional AIT is effective but has poor patient compliance and is not suitable for food allergies.
• New AIT methods, including novel administration routes and hypoallergenic products, show promise.
• Allergen-specific monoclonal antibodies offer potential for passive immunotherapy.

Conclusions:

• There is a critical need for improved AIT methods that are effective, safe, and compliant.
• Innovations in AIT, such as new delivery systems and biologics, are expanding treatment possibilities.
• Future research directions include enhanced adjuvants and passive immunotherapy options.